Company intelligence / Profile preview

Sanara Capital

Ownership: Private
Development stage: Preclinical

Overview

Sanara Capital is an active Israeli venture capital fund specializing in digital health, bio-convergence, and medical devices. It invests primarily in A & B financing rounds of Israeli-related startups both domestically and internationally. The firm supports nearly 20 active portfolio companies across two funds and leverages strategic partnerships with Philips Healthcare and Teva Pharmaceuticals for industry expertise and value creation.

Modalities: DeviceDigital health platformBiologic (bio-convergence)
Industry: Investors

Partnerships

Philips HealthcareTeva Pharmaceuticals

Beyond the preview

Go deeper on Sanara Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sanara Capital.

Explore the full profile